Tillman U. Gerngross |
Co-Founder and CEO e-mail
- Co-founder and CSO, GlycoFi, Inc. (acquired by Merck 2006)
- Professor of Bioengineering, Dartmouth College
- Venture Partner, SV Life Sciences
K. Dane Wittrup |
Co-Founder, Office of the CSO, Chairman of the SAB e-mail
- Co-founder, BioDisplay Technologies (acquired by Abbott Laboratories 2001)
- Professor of Chemical Engineering and Bioengineering, Massachusetts Institute of Technology
Errik B. Anderson |
COO e-mail
- Lehman Brothers Venture Capital (now Tenaya Capital)
- Tuck School of Business
- Founder and President, Seven West Ventures
Michael Feldhaus |
Executive VP of Antibody Discovery e-mail
- Director of Protein Engineering, Merrimack Pharmaceuticals
- Senior Research Scientist, Pacific Northwest National Laboratory
Guy Van Meter |
Vice President, Head of Business Development e-mail
- Business Development and Strategic Alliances, Pfizer, Inc.
- Business Development, Technology Licensing, Dyax Corp.
- F.W. Olin Graduate School of Management at Babson
Max Vasquez |
Vice President of Computational Biology e-mail
- Senior Director, Research, PDL BioPharma
- Bocaraca Consulting, Founder and President
Joanne Sun |
Senior Director of Protein Analytics and High Throughput Purification e-mail
- Director, Protein Analytics, Adnexus Therapeutics (acquired by Bristol-Myers Squibb in 2007)
- Associate Director, Analytical Biochemistry, Bristol-Myers Squibb
- Group Leader, Protein Analytics, Abbott Bioresearch Center
Piotr Bobrowicz |
Director of Technology and Platform Development e-mail
- Group Leader, High Throughput Strain Screening, Merck & Co., Inc.
- Senior Scientist, Strain Development, GlycoFi, Inc.
Xiaolin Liu |
Director of High Throughput Expression e-mail
-Senior Research Scientist, Project Manager, Cell Culture Process Development, Bristol-Myers Squibb
-Scientist, Process Development in Technical Operation, Abbott Bioresearch Center
Philip Chase |
General Counsel e-mail
-General Counsel, Alnylam Pharmaceuticals, Inc.
-General Counsel, Epix Pharmaceuticals, Inc.
-Chief Corporate Counsel, Transkaryotic Therapies, Inc. (TKT)